Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2024-2032

Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112023A1155
Year End sale Buy Now

Market Overview:

The global travel vaccines market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.6% during 2024-2032. The introduction of combination vaccines in immunization program, rising demand for needle free techniques, and favorable government initiatives represent some of the key factors driving the market.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 4.0 Billion
Market Forecast in 2032
US$ 9.4 Billion
Market Growth Rate 2024-2032 9.6%


Favorable Government Initiatives Augmenting Market Growth

The travel vaccines market has been experiencing continuous growth due to favorable government initiatives. Various governing and non-governing agencies are encouraging the adoption of travel vaccines that currently represent one of the primary drivers of the travel vaccines market. They also provide important travel health updates through various websites to travelers that assist in finding the nearest travel clinic and guide tourists about exact vaccinations as per the travel destination. Moreover, they are conducting awareness programs to increase vaccine coverage across the globe.

Global Travel Vaccines Market

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is fragmented with a few international and regional players in the industry. The volume of new entrants is moderate in the travel vaccines industry due to low product differentiation and high capital investments in the industry.

What are Travel Vaccines?

Vaccines refer to biological preparations that protect the human body against severe and potentially deadly diseases. They comprise an agent that is manufactured from the surface protein, toxins, or weakened or killed forms of the disease-causing microorganism. They allow the body to produce antibodies, which act as a shield and protect individuals from viruses. Vaccines are also taken by travelers a few weeks prior to their visit to certain regions or countries. Travel Vaccines are effective in preventing numerous serious diseases, such as hepatitis A, diphtheria, pertussis and tetanus (DPT), yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, and Japanese encephalitis, among individuals.

COVID-19 Impact:

The COVID-19 pandemic outbreak caused a severe problem for the travel vaccines industry and imposed unprecedented challenges on numerous countries. The imposition of stringent movement and travel bans across the globe has hampered the demand for travel vaccines. In addition, there has been a massive decline in travel vaccine supplies on account of the travel restrictions. Due to the global lockdown, many production plants were not operational or temporarily closed and shortage or unavailability of labor was observed around the world. Moreover, the production of travel vaccines was constrained due to the ban on exports of raw materials from one country to another. The drastic drop in passenger air transport due to the COVID-19 pandemic and containment measures hindered the sales of travel vaccines. Besides this, there was a shifting preference toward coronavirus vaccines as compared to travel vaccines across the globe. The pandemic had a huge impact on the tourism industry, as many countries have introduced travel restrictions to prohibit the expansion of viruses. Additionally, people preferred to stay at home rather than visit various countries around the world. However, post-pandemic, governing agencies of various countries have relaxed lockdown restrictions on the travel and tourism industry, which is expected to boost the demand for travel vaccines worldwide in the coming years.   

Travel Vaccines Market Trends:

At present, the increasing prevalence of life-threatening infectious diseases among the masses worldwide represents one of the major factors impelling the growth of the market.  Moreover, the introduction of combination vaccines in immunization programs that offer immunity against various diseases among individuals across the globe is strengthening the growth of the market. Apart from this, the growing utilization of travel vaccines due to the increasing number of international tourist arrivals for various purposes is offering a positive market outlook. In addition to this, governing and non-governing agencies of various countries are encouraging the adoption of travel vaccines by conducting awareness programs, which is contributing to the growth of the market. Besides this, technological advancements, such as needle-free injection technology (NFIT), which eliminates the chances of needle stick injuries and avoids other complications among individuals, is offering lucrative growth opportunities to industry investors. Additionally, there is a rise in the demand for effective and cost-efficient travel vaccines among the masses around the world. This, coupled with the increasing awareness among travelers to protect themselves from numerous diseases, is bolstering the growth of the market. Furthermore, the rising adoption of travel vaccines in various countries where vaccines are mandatory prior to visit the place is supporting the growth of the market.

 

 
 

 

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global travel vaccines market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on composition and disease.

Composition Insights:

 

 
 

 

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Mono Vaccines
  • Combination Vaccines
     

The report has provided a detailed breakup and analysis of the travel vaccines market based on the composition. This includes mono vaccines and combination vaccines. According to the report, combination vaccines represented the largest segment, as they provide protection against more than one disease. These vaccines assist in reducing the number of injections required by the users. In addition to this, the rising adoption of combination vaccines among pediatric population, as infants are more susceptible to various infectious diseases due to their weak immune systems, which is supporting the market growth of the segment.  

Disease Insights:

  • Hepatitis A 
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others
     

A detailed breakup and analysis of the travel vaccines market based on the disease has also been provided in the report. This includes hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese encephalitis, and others. According to the report, hepatitis A accounted for the largest market share, as it is a viral disease that can be transmitted through direct contact with an infectious person or consumption of contaminated food and water. In line with this, the rising utilization of effective hepatitis A vaccine among the travelers to prevent various diseases, is bolstering the growth of the market.            

Regional Insights:

 

 
 

 

To get more information on the regional analysis of this market, Request Sample

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America
     

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for travel vaccines. Some of the factors driving the North America travel vaccines market included the presence of key market players, rising prevalence of life-threatening infectious diseases among individuals, and the increasing production of vaccines. In addition to this, various manufacturers are introducing superior range of travel vaccines, such as a vaccine against varicella. Besides this, companies having travel vaccine franchises are offering vaccines to treat numerous diseases, such as influenza, meningitis, rabies, tick-borne encephalitis, Haemophilus influenzae B (Hib), polio, diphtheria, tetanus, and pertussis, which is strengthening the market growth in the region.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global travel vaccines market. Some of the companies covered in the report include:

  • GlaxoSmithKline Pharmaceuticals Limited
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abelló A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc.
     

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Composition, Disease, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered GlaxoSmithKline Pharmaceuticals Limited, Sanofi Pasteur, Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories and Hoffmann-La Roche, Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the travel vaccines market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global travel vaccines market.
  • The study maps the leading, as well as the fastest-growing, regional markets.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the travel vaccines industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global travel vaccines market was valued at US$ 4.0 Billion in 2023.

We expect the global travel vaccines market to exhibit a CAGR of 9.6% during 2024-2032.

The rising incidences of life-threatening and infectious diseases, such as such as diphtheria, Japanese encephalitis, meningitis, yellow fever, etc., are primarily driving the global travel vaccines market.

The sudden outbreak of the COVID-19 pandemic had led to the implementation of stringent lockdown regulations across several nations, resulting in the temporary restrictions on intra- and inter-national travel activities, thereby negatively impacting the global market for travel vaccines.

Based on the composition, the global travel vaccines market has been segmented into mono vaccines and combination vaccines. Currently, combination vaccines exhibit a clear dominance in the market.

Based on the disease, the global travel vaccines market can be divided into hepatitis A, DPT, yellow fever, typhoid, hepatitis B, measles and mumps, rabies, meningococcal, varicella, Japanese Encephalitis, and others. Among these, hepatitis A holds the largest market share.

On a regional level, the market has been classified into Asia Pacific, North America, Europe, Middle East and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global travel vaccines market include GlaxoSmithKline Pharmaceuticals Limited, Sanofi Pasteur, Merck & Co., Inc., Novartis AG, Pfizer Inc., ALK-Abelló A/S, Bavarian Nordic A/S, Crucell (Subsidiary of Johnson & Johnson), CSL Limited, AstraZeneca PLC, Altimmune, Inc., Abbott Laboratories, Hoffmann-La Roche, Inc., etc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2024-2032
Purchase options Year End sale



Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More